Patents by Inventor Henrik S. Andersen

Henrik S. Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIQUID PHARMACEUTICAL COMPOSITION OF FACTOR VII POLYPEPTIDE
    Publication number: 20150273027
    Abstract: The invention relates to a liquid, aqueous pharmaceutical composition comprising a Factor VIIa polypeptide, a buffering agent suitable for keeping pH in the range of from about 5.5 to about 8.5; and an active site stabilizing agent, which is selected from the group of: (S)-2-{2-[5-(5-carbamimidoyl-1H-benzoimidazol-2-yl)-6,2?-dihydroxy-5?-sulfamoyl-biphenyl-3-yl]acetylamino}-succinic acid or a pharmaceutically acceptable salt thereof; (R)-2-{2-[5-(5-carbamimidoyl-1H-benzoimidazol-2-yl)-6,2?-dihydroxy-5?-sulfamoyl-biphenyl-3-yl]acetylamino}-succinic acid or a pharmaceutically acceptable salt thereof; and a mixture of the (S)- and (R)-forms or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: October 10, 2013
    Publication date: October 1, 2015
    Inventors: Prafull S. Gandhi, Anette Henriksen, Charlotte C. Rossmeisl, Hanne B. Rasmussen, Henrik S. Andersen, Soeren E. Bjoern
  • N-substituted azaheterocyclic carboxylic acids and esters thereof
    Patent number: 5595989
    Abstract: The present invention relates to novel N-substituted azaheterocyclic carboxylic acids and esters thereof in which a substituted alkyl chain forms part of the N-substituent or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation.
    Type: Grant
    Filed: January 3, 1995
    Date of Patent: January 21, 1997
    Assignee: Novo Nordisk A/S
    Inventors: Knud E. Andersen, Uffe B. Olsen, Hans Petersen, Frederik Gr.o slashed.nvald, Ursula Sonnewald, Tine K. J.o slashed.rgensen, Henrik S. Andersen
  • Substituted 2-imidazolines and use thereof
    Patent number: 5262430
    Abstract: The invention relates to novel substituted 2-imidazolines (I) having a lowering effect on blood glucose in mammals, to their preparation, to pharmaceutical compostions containing them and to their use.
    Type: Grant
    Filed: December 16, 1991
    Date of Patent: November 16, 1993
    Assignee: Novo Nordisk A/S
    Inventors: Poul Borrevang, Henrik S. Andersen